Aminorex, with the CAS number 2207-50-3, is a synthetic compound that belongs to the class of phenethylamines. It is structurally related to amphetamines and is known for its stimulant properties. Aminorex acts primarily as a central nervous system stimulant, and it has been studied for its potential effects on appetite suppression and weight loss. The compound is characterized by its ability to increase the release of neurotransmitters such as dopamine and norepinephrine, which can enhance alertness and energy levels. However, due to its stimulant effects, aminorex has been associated with various side effects, including increased heart rate, anxiety, and potential for abuse. It is important to note that aminorex is not widely used in clinical practice and is often considered a controlled substance in many jurisdictions due to its potential for misuse and adverse health effects. As with any chemical substance, safety and regulatory considerations are paramount when discussing its characteristics and applications.

Aminorex

2207-50-3: 2-Amino-4,5-dihydro-5-phenyloxazol, 2-Amino-5-phenyl-2-oxazoline, 2-Oxazolamine, 4,5-dihydro-5-phenyl-, 2-Oxazoline, 2-amino-5-phenyl-, 4,5-Dihydro-5-phenyl-2-oxazolamine, 5-Phenyl-4,5-Dihydro-1,3-Oxazol-2-Amine, Aminorex [USAN:INN:BAN], Aminorexum, Aminorexum [INN-Latin], Aminoxafen, Aminoxaphen, Apiquel, Cpdd 0039, DEA No. 1585, Hsdb 7596, McN 742, NSC 66592, Nsc 66952, Unii-2Sh16612I9,  Aminorex

Applications Aminorex is a metabolite of Levamisole (L331100). Aminorex is an anorectic stimulant drug of the 2-amino-5-aryl oxazoline class. Aminorex has been shown to have locomotor stimulant effects similar to Methamphetamine (M258795).
References Poos, G., et al.: J. Med. Chem., 6, 266 (1963), Watson, A., et al.: Res. Vet. Sci., 45, 411 (1988), Russell, B., et al.: Pharmacol. Biochem. Behav., 51, 375 (1995),


CAS 2207-50-3: Aminorex

Aminorex

Ref: TR-A629200

Aminorex (1mg/ml in Acetonitrile)

Ref: TR-KIT1165